Literature DB >> 27927334

Screw Versus Hybrid Constructs for Flexible Thoracic Curves in Adolescent Idiopathic Scoliosis: A Prospective, Randomized Study.

Lawrence L Haber1, Joshua D Hughes2, Erika D Womack3, Rowland M Roberson3, Patrick B Wright3.   

Abstract

STUDY
DESIGN: Prospective, computer-randomized design.
OBJECTIVE: Compare screw and hybrid constructs in flexible, thoracic curves for adolescent idiopathic scoliosis (AIS) in a prospective randomized fashion. SUMMARY OF
BACKGROUND: The consensus in scientific literature is that all-screw constructs correct AIS better than hooks in the lumbar and in large, stiff thoracic curves. However, debate continues whether all-screw constructs outperform hybrid constructs in small, flexible thoracic AIS. To our knowledge, this is the first prospective, randomized scoliosis study that examines measures of correction and patient satisfaction with the Scoliosis Research Society-30 (SRS-30) questionnaire.
METHODS: A total of 45 enrolled AIS patients with flexible, thoracic curves were given an identification number with an associated computer-generated randomization to the hybrid (n = 22) or screw group (n = 23). The treating surgeon received the randomization 2-3 days before surgery. Data including major Cobb (MC), truncal rotation (TR), rib index (RI), secondary curve (SC), and SRS-30 questionnaire were collected preoperatively and postoperatively at 4 weeks and 3, 6, 12, and 24 months.
RESULTS: Thirty-seven patients in the hybrid (n = 18) and screw (n = 19) groups completed the study with a mean follow-up of 26 months (range, 24-49 months). Hybrid versus screw group means for preoperative, postoperative, and final follow-up were: MC 58° ± 8° versus 55° ± 6°, 18° ± 8° versus 15° ± 7°, and 23°± 8° versus 14° ± 6°; TR 14° ± 6° versus 16° ± 4°, 10° ± 5° versus 7° ± 3°, and 11° ± 5° versus 7° ± 4°; RI 3.0° ± 1.2° versus 3.4° ± 1.4°, 2.5° ± 0.7° versus 1.8° ± 0.6°, and 2.5° ± 0.8° versus 2.0° ± 0.5°; SC 35° ± 13° versus 31° ± 8°, 13° ± 11° versus 7° ± 9°, and 13° ± 12° versus 7° ± 7°; and SRS-30 3.9 ± 0.2 versus 3.9 ± 0.2, 4.1 ± 0.4 versus 4.0 ± 0.3, and 4.1 ± 0.3 versus 4.0 ± 0.2.
CONCLUSIONS: Intergroup preoperative and early postoperative values were comparable (p > .05). At final follow-up, owing to loss of correction in the hybrid group, differences in MC (9°; p = .000), RI (0.54; p = .016), and TR (4°; p = .039) correction were statistically significant as SC trended toward significance (6°; p = .052). All-screw constructs outperformed hybrid constructs, especially over time. No differences in SRS-30 scores occurred between groups.
Copyright © 2014 Scoliosis Research Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIS; Flexible; Hybrid; Screw; Thoracic

Year:  2014        PMID: 27927334     DOI: 10.1016/j.jspd.2014.05.005

Source DB:  PubMed          Journal:  Spine Deform        ISSN: 2212-134X


  3 in total

1.  Letter to the editor concerning: "a comprehensive review of thoracic deformity parameters in scoliosis" by Jonathan A. Harris, Oscar H. Mayer, Suken A. Shah, Robert M. Campbell Jr., Sriram Balasubramanian. Eur Spine J (2014) 23:2594-2602, DOI 10.1007/s00586-014-3580-8.

Authors:  Theodoros B Grivas
Journal:  Eur Spine J       Date:  2015-01-31       Impact factor: 3.134

Review 2.  Pedicle screw versus hybrid instrumentation in adolescent idiopathic scoliosis: A systematic review and meta-analysis with emphasis on complications and reoperations.

Authors:  Ming Luo; Ning Li; Mingkui Shen; Lei Xia
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

3.  Post-marketing surveillance on safety and efficacy of posterior spinal correction and fusion with the CD Horizon Solera instrumentation for adolescent idiopathic scoliosis. A retrospective cohort study.

Authors:  Lotte Deirdre Elizabeth Dingena Maria Smals; Marcus Hubertus Harrietta Maria Hulsbosch; Sjoerd Ian Patrick Jozef de Faber; Jacobus J C Arts; Lodewijk W van Rhijn; Paul Cornelis Willems
Journal:  N Am Spine Soc J       Date:  2021-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.